# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY AND INSTRUMENT COMBINATION TEMPLATE

A. 510(k) Number: k072018   
B. Purpose for Submission: New submission for glucose, sodium, potassium and chloride on a new analyzer   
C. Measurand: Glucose, Sodium, Potassium, Chloride   
D. Type of Test: Quantitative photometric and Ion Selective Electrode   
E. Applicant: Shenzhen Mindray Bio-Medical Electronics Co., Ltd   
F. Proprietary and Established Names: BS-200 Chemistry Analyzer, Mode BS-200

# G. Regulatory Information:

1. Regulation section: 21CFR Sec.-862.1345 Glucose test system. 21CFR Sec.-862.1665 Sodium test system. 21CFR Sec.-862.1600 Potassium test system. 21CFR Sec.-862.1170 Chloride test system. 21CFR Sec.- 862.2160-Discrete photometric chemistry analyzer for clinical use.

2. Classification: Class II for assays Class I for analyzer (reviewed as part of Class II test systems)

3. Product code: CFR - hexokinase, glucose JGS - electrode, ion specific, sodium CEM - electrode, ion specific, potassium CGZ - electrode, ion-specific, chloride JJE - analyzer, chemistry (photometric, discrete), for clinical use

4. Panel: Chemistry (75)

# H. Intended Use:

1. Intended use(s): See indications for use below

Potassium measurements monitor electrolyte balance and in the diagnosis and treatment of diseases conditions characterized by low or high blood potassium levels.

Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders.

Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.

3. Special conditions for use statement(s): Prescription use   
4. Special instrument requirements: BS-200 Chemistry Analyzer

# I. Device Description:

The BS-200 is an automated chemistry analyzer for in vitro diagnostic use in clinical laboratories and designed for in vitro quantitative determination of clinical chemistries in serum, plasma and urine samples. The device is composed of a photometric module and an Ion Selective Electrode module.

The Glucose reagent is ready to use and the composition is Liquid Glucose (Hexokinase) Reagent: Hexokinase (yeast) $4 0 0 0 \mathrm { U / L }$ , G6PDH (Leuconostoc mesenteroides) $4 0 0 0 \mathrm { U / L }$ , ATP $6 . 0 \mathrm { m M }$ , NAD $3 . 0 \mathrm { m M }$ , Buffer pH $7 . 5 \pm 0 . 1$ , Nonreactive stabilizers, and sodium azide $( 0 . 1 \% )$ as preservative. The reagent is manufactured by Point Scientific for Shenzhen Mindray Bio-Medical.

The ISE module consists of ion selective electrodes for sodium, potassium, and chloride, a reference electrode and accessory reagents. The module is manufactured for Midray by Medica. The electrodes and accessory reagents were also previously cleared as the Medica Easyelectrolyte Analyzer and Rapidlyte Analyzer (k000926).

J. Substantial Equivalence Information:

1. Predicate device name(s): Roche, Hitachi 911 analyzer Point Scientific Glucose reagent Medica Easyelectrolyte Analyzer and Rapidlyte Analyzer   
2. Predicate 510(k) number(s): k953239 k002199   
3. k000926

<table><tr><td rowspan=1 colspan=1>ComparisonSection</td><td rowspan=1 colspan=1>BS-200</td><td rowspan=1 colspan=1>BoehringerMannheim/Hitachi917 analyzer</td><td rowspan=1 colspan=1>EasyElectroLyte/RapidLyte Na/K/ClAnalyzer</td></tr><tr><td rowspan=1 colspan=1>510(K) Number</td><td rowspan=1 colspan=1>Pending</td><td rowspan=1 colspan=1>k953239</td><td rowspan=1 colspan=1>k000926</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>The BS-200 ChemistryAnalyzer is designedfor clinical laboratoryuse, making directquantitativemeasurements of Na+(sodium), K+(potassium), Cl-(chloride) in serum,plasma and urinesamples and Glucose inserum samples.Additionally, othervarious chemistryassays may beadaptable to theanalyzer depending onthe reagent used toinduce a photometricreaction.</td><td rowspan=1 colspan=1>The BoehringerMannheim/Hitachi917 analyzer isintended for thequantitative andqualitativemeasurement ofanalytes in bodyfluids.</td><td rowspan=1 colspan=1>EasyElectroLyte/RapidLyte Na/K/ClAnalyzer is designedfor clinical laboratoryuse by laboratoryprofessionals to assessthe levels of Na+(sodium), K+(potassium), and Cl-(chloride) found inwhole blood, serum,plasma, and urine ofpatients. The analysisis performed in-vitro,and neither theanalyzer nor any of itscomponents come incontact with thepatient.</td></tr><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>None</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ISE (K,Na,Cl)</td><td rowspan=1 colspan=1>ISE( K,Na,Cl)</td><td rowspan=1 colspan=1>ISE (K,Na,Cl)</td></tr></table>

# BS-200 and (Roche) Boehringer Mannheim/Hitachi 917 analyzer

<table><tr><td colspan="1" rowspan="2">b</td><td colspan="1" rowspan="1">Feature</td><td colspan="1" rowspan="1">BS-200</td><td colspan="1" rowspan="1">Boehringer Mannheim/Hitachi917 analyzer</td><td colspan="1" rowspan="1">SID</td></tr><tr><td colspan="1" rowspan="1">510(K)</td><td colspan="1" rowspan="1">Pending</td><td colspan="1" rowspan="1">510(k) Number k953239</td><td colspan="1" rowspan="1">|</td></tr><tr><td colspan="1" rowspan="1">1</td><td colspan="4" rowspan="1">Standards</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">IEC 61010-1</td><td colspan="1" rowspan="1">IEC 61010-1</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="3" rowspan="1">System Function</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">b</td><td colspan="1" rowspan="1">System Control</td><td colspan="1" rowspan="1">Automatic,microprocessorcontrolled</td><td colspan="1" rowspan="1">Automatic, microprocessorcontrolled</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1">b</td><td colspan="1" rowspan="1">LIS externalconnectivitycapability</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Calibration/QC</td><td colspan="1" rowspan="1">Automatic and Manualcalibration/QC</td><td colspan="1" rowspan="1">Automatic and Manualcalibration/QC</td><td colspan="1" rowspan="1">s</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Barcode</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">Throughput (Max)</td><td></td><td></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">200 photometric testsper hour330 tests per hour withISE</td><td colspan="1" rowspan="1">800 photometric tests per hour1200 tests per hour with ISE</td><td colspan="1" rowspan="1">D</td></tr><tr><td colspan="1" rowspan="2">b</td><td colspan="1" rowspan="1">Feature</td><td colspan="1" rowspan="1">BS-200</td><td colspan="1" rowspan="1">Boehringer Mannheim/Hitachi917 analyzer</td><td colspan="1" rowspan="1">S/D</td></tr><tr><td colspan="1" rowspan="1">510(K)</td><td colspan="1" rowspan="1">Pending</td><td colspan="1" rowspan="1">510(k) Number k953239</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Configuration</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Analytical unit,Operational Unit</td><td colspan="1" rowspan="1">Analytical unit, OperationalUnit</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">Principle of Analysis</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Mode of detection</td><td colspan="1" rowspan="1">Photometric</td><td colspan="1" rowspan="1">Photometric</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1">′</td><td colspan="1" rowspan="1">Analytical methods</td><td colspan="1" rowspan="1">Endpoint with sampleblankingFied-timeKinetic</td><td colspan="1" rowspan="1">Endpoint with sample blankingEndpointKinetics</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Calibration methods</td><td colspan="1" rowspan="1">Linear calibration andnonlinear calibration</td><td colspan="1" rowspan="1">Linear calibration andnonlinear calibration</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">Optical Measurement Unit</td><td colspan="1" rowspan="1">t Unit</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">MeasurementModes</td><td colspan="1" rowspan="1">Absorbance</td><td colspan="1" rowspan="1">Absorbance</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Optical Modes</td><td colspan="1" rowspan="1">Monochromatic,Bichromatic</td><td colspan="1" rowspan="1">Monochromatic, Bichromatic</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1">′</td><td colspan="1" rowspan="1">Wavelength</td><td colspan="1" rowspan="1">340nm, 405nm, 450nm,510nm, 546nm, 578nm,630nm, 670nm</td><td colspan="1" rowspan="1">340nm, 376nm, 415nm, 450nm, 505nm, 546nm, 570 nm,600 nm, 660nm, 700nm, 800nm</td><td colspan="1" rowspan="1">D</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Linear absorbancerange</td><td colspan="1" rowspan="1">0.0000-4.0000absorbance</td><td colspan="1" rowspan="1">0.0000-2.5000 absorbance</td><td colspan="1" rowspan="1">D</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Light Source</td><td colspan="1" rowspan="1">Tungsten halogen lamp</td><td colspan="1" rowspan="1">Tungsten halogen lamp</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Detector</td><td colspan="1" rowspan="1">Photodiode</td><td colspan="1" rowspan="1">Photodiode</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">Reaction Unit</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Reaction cuvettes</td><td colspan="1" rowspan="1">Plastics, 80 disposable</td><td colspan="1" rowspan="1">Plastics, 160 semi-disposable</td><td colspan="1" rowspan="1">D</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Reaction volume</td><td colspan="1" rowspan="1">180~500uL</td><td colspan="1" rowspan="1">180~380uL</td><td colspan="1" rowspan="1">D</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Path length</td><td colspan="1" rowspan="1">5mm</td><td colspan="1" rowspan="1">5mm</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Reactiontemperature</td><td colspan="1" rowspan="1">37°</td><td colspan="1" rowspan="1">37</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">Sample and Reagent System</td><td colspan="1" rowspan="1">System</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Sample tube/reagent bottlepositions</td><td colspan="1" rowspan="1">40 sample tube positionson the outer circle and40  reagent   bottlepositions on the innercircle</td><td colspan="1" rowspan="1">110 positions on sample disk 1,60 positions on sample disk 2;45 positions on reagent disk1(R1), 44 positions on reagentdisk 2(R2)</td><td colspan="1" rowspan="1">D</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Pipettor System</td><td colspan="1" rowspan="1">Positive displacementstepper motor driven</td><td colspan="1" rowspan="1">Positive displacement steppermotor driven</td><td colspan="1" rowspan="1">S</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Refrigeratortemperature</td><td colspan="1" rowspan="1">4-15°C</td><td colspan="1" rowspan="1">2-12°</td><td colspan="1" rowspan="1">D</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Sample Dispense</td><td colspan="1" rowspan="1">3µl -45μl</td><td colspan="1" rowspan="1">2-35μl</td><td colspan="1" rowspan="1">D</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Reagent Dispense</td><td colspan="1" rowspan="1">30μl-450μl</td><td colspan="1" rowspan="1">20-270μl</td><td colspan="1" rowspan="1">D</td></tr><tr><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">POWER</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Input</td><td colspan="1" rowspan="1">100-130V~50/60±1 Hz</td><td colspan="1" rowspan="1">115V±10v AC, 60±0.5 Hz</td><td colspan="1" rowspan="1">D</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Consumption</td><td colspan="1" rowspan="1">1000 VA (max.)</td><td colspan="1" rowspan="1">3kVA</td><td colspan="1" rowspan="1">D</td></tr><tr><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">Operating environmental conditions</td><td colspan="1" rowspan="1">ntal conditions</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Temperature</td><td colspan="1" rowspan="1">+15°C to +30°</td><td colspan="1" rowspan="1">+15°C to +32°C</td><td colspan="1" rowspan="1">D</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Humidity</td><td colspan="1" rowspan="1">35% to 80%, non-condensing</td><td colspan="1" rowspan="1">45% to 85% relative humidity</td><td colspan="1" rowspan="1">D</td></tr></table>

BS-200 and Easy Electrolytes   

<table><tr><td rowspan=2 colspan=1>b</td><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>BS-200</td><td rowspan=1 colspan=1>EasyElectroLyte/RapidLyteNa/K/Cl Analyzer</td><td rowspan=1 colspan=1>S/D</td></tr><tr><td rowspan=1 colspan=1>510(K)</td><td rowspan=1 colspan=1>Pending</td><td rowspan=1 colspan=1>510(k) Number K000926</td><td rowspan=1 colspan=1>/</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=4>Principle</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ISE (ion selectiveelectrode technology)</td><td rowspan=1 colspan=1>ISE (ion selective electrodetechnology)</td><td rowspan=1 colspan=1>S</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=4>Sample Type</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Serum, plasma, ordiluted urine</td><td rowspan=1 colspan=1>Serum, plasma, or diluted urine</td><td rowspan=1 colspan=1>S</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=4>Test</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Na+, K+, Cl</td><td rowspan=1 colspan=1>Na+, K+, Cl</td><td rowspan=1 colspan=1>S</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=4>Sample Size</td></tr><tr><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>70 μL Serum, plasmamode; 140 μL Urinemode</td><td rowspan=1 colspan=1>55 μL Serum, plasma mode;300 μL Urine mode</td><td rowspan=1 colspan=1>D</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=4>ISE Calibration</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Two-point and single-point calibrations</td><td rowspan=1 colspan=1>Two-point and single-pointcalibrations</td><td rowspan=1 colspan=1>S</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

IEC 61010-1 - Safety Requirements for Electrical Equipment for Measurement, Control, and Laboratory Use - Part 1   
• ISO14971 - Medical devices — Application of risk management to medical devices   
• CLSI - Evaluation of Precision Performance of Clinical Chemistry Devices - EP05-A2   
• CLSI - Evaluation of the Linearity of Quantitative Analytical Methods - EP06-A   
• CLSI - Interference Testing in Clinical Chemistry - EP07-A2   
• CLSI - Method Comparison and Bias Estimation Using Patient Samples - EP09-A2   
• CLSI - Protocols for Determination of Limits of Detection and Limits of Quantitation - EP17-A

# L. Test Principle:

Glucose   
This method uses hexokinase and glucose-6-phosphate-dehydrogenase to catalyze the   
reaction:

Glucose is phosphorylated with adenosine triphosphate (ATP) in the reaction catalyzed by hexokinase (HK). The product, glucose–6-phosphate (G6P) is then oxidized with the concomitant reduction of nicotinamide adenine dinucleotide (NAD) to NADH in the reaction catalyzed by glucose-6-phosphate-dehydrogenase (G6PDH). The formation of NADH causes an increase in absorbance at $3 4 0 \mathrm { n m }$ . The increase is directly proportional to the amount of glucose in the sample.

The ion selective electrodes develop a voltage that varies with the concentration of the ion $( \mathrm { N a } ^ { + } , \mathrm { K } ^ { + }$ , Cl- ) to which they are specific. The relationship between the voltage developed and the concentration of the sensed ion is logarithmic and calculated by the Nernst equation.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility: Glucose Precision studies were performed using control serum samples at low, middle and high concentration. The studies were conducted for 20 days with two runs per day and duplicates per run according to CLSI EP5-A2 document.

<table><tr><td rowspan=1 colspan=4>Within-Run</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>S.D.</td><td rowspan=1 colspan=1>C.V.%</td><td rowspan=1 colspan=1>N</td></tr><tr><td rowspan=1 colspan=1>56</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>122</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>296</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>80</td></tr></table>

<table><tr><td rowspan=1 colspan=4>Between-day</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>S.D.</td><td rowspan=1 colspan=1>C.V.%</td><td rowspan=1 colspan=1>N</td></tr><tr><td rowspan=1 colspan=1>56</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>122</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>296</td><td rowspan=1 colspan=1>4.9</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>80</td></tr></table>

# ISE Serum Mode

Precision studies were performed following a modification of the guidelines contained in CLSI document EP5-A2. The testing was conducted in duplicate for 20 days with two runs per day. The results are summarized in the tables below.

Within-run precision   

<table><tr><td rowspan=2 colspan=1>Item</td><td rowspan=1 colspan=3>Level I</td><td rowspan=1 colspan=3>Level II</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV%</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=1>K mmol/L</td><td rowspan=1 colspan=1>4.11</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.7%</td><td rowspan=1 colspan=1>6.77</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.8%</td></tr><tr><td rowspan=1 colspan=1>Na mmol/L</td><td rowspan=1 colspan=1>136.13</td><td rowspan=1 colspan=1>0.61</td><td rowspan=1 colspan=1>0.4%</td><td rowspan=1 colspan=1>146.74</td><td rowspan=1 colspan=1>0.72</td><td rowspan=1 colspan=1>0.5%</td></tr><tr><td rowspan=1 colspan=1>Cl mmol/L</td><td rowspan=1 colspan=1>99.59</td><td rowspan=1 colspan=1>0.73</td><td rowspan=1 colspan=1>0.7%</td><td rowspan=1 colspan=1>115.68</td><td rowspan=1 colspan=1>0.52</td><td rowspan=1 colspan=1>0.5%</td></tr></table>

Day-to-Day precision   

<table><tr><td rowspan=2 colspan=1>Item</td><td rowspan=1 colspan=3>Level I</td><td rowspan=1 colspan=3>Level II</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV%</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=1>K mmol/L</td><td rowspan=1 colspan=1>4.11</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>6.77</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>1.0%</td></tr><tr><td rowspan=1 colspan=1>Na mmol/L</td><td rowspan=1 colspan=1>136.13</td><td rowspan=1 colspan=1>2.12</td><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>146.74</td><td rowspan=1 colspan=1>1.66</td><td rowspan=1 colspan=1>1.1%</td></tr><tr><td rowspan=1 colspan=1>CL mmol/L</td><td rowspan=1 colspan=1>99.59</td><td rowspan=1 colspan=1>1.78</td><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>115.68</td><td rowspan=1 colspan=1>1.13</td><td rowspan=1 colspan=1>1.0%</td></tr></table>

ISE Urine Mode Within-run precision   

<table><tr><td rowspan=2 colspan=1>Item</td><td rowspan=1 colspan=3>Level I</td><td rowspan=1 colspan=3>Level II</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV%</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=1>K mmol/L</td><td rowspan=1 colspan=1>37.09</td><td rowspan=1 colspan=1>0.46</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>67.49</td><td rowspan=1 colspan=1>0.63</td><td rowspan=1 colspan=1>0.9%</td></tr><tr><td rowspan=1 colspan=1>Na mmol/L</td><td rowspan=1 colspan=1>99.23</td><td rowspan=1 colspan=1>1.13</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>170.84</td><td rowspan=1 colspan=1>1.36</td><td rowspan=1 colspan=1>0.8%</td></tr><tr><td rowspan=1 colspan=1>CL mmol/L</td><td rowspan=1 colspan=1>82.90</td><td rowspan=1 colspan=1>1.36</td><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>132.16</td><td rowspan=1 colspan=1>1.24</td><td rowspan=1 colspan=1>0.9%</td></tr></table>

Day-to-Day precision   

<table><tr><td rowspan=2 colspan=1>Item</td><td rowspan=1 colspan=3>Level I</td><td rowspan=1 colspan=3>Level II</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV%</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=1>K mmol/L</td><td rowspan=1 colspan=1>37.09</td><td rowspan=1 colspan=1>0.48</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>67.49</td><td rowspan=1 colspan=1>0.70</td><td rowspan=1 colspan=1>1.0%</td></tr><tr><td rowspan=1 colspan=1>Na mmol/L</td><td rowspan=1 colspan=1>99.23</td><td rowspan=1 colspan=1>1.68</td><td rowspan=1 colspan=1>1.7%</td><td rowspan=1 colspan=1>170.84</td><td rowspan=1 colspan=1>2.41</td><td rowspan=1 colspan=1>1.4%</td></tr><tr><td rowspan=1 colspan=1>CL mmol/L</td><td rowspan=1 colspan=1>82.90</td><td rowspan=1 colspan=1>1.50</td><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>132.16</td><td rowspan=1 colspan=1>2.12</td><td rowspan=1 colspan=1>1.6%</td></tr></table>

b. Linearity/assay reportable range: The reportable ranges of the assays are as follows:

Glucose $\mathrm { = 1 - 6 0 0 \ m g / d l }$ Potassium $= 1 . 1 - 8 . 6 \mathrm { m m o l / L }$ Sodium $= 1 1 3 - 1 9 4 \mathrm { m m o l / L }$ Chloride $= 5 3 - 1 5 4 \mathrm { m m o l / L }$

ISE Urine mode Potassium $\mathrm { \Lambda } = 1 3 - 1 8 4 \mathrm { m m o l / L }$ Sodium $= 2 7 - 3 7 2 \mathrm { m m o l / L }$ Chloride $= 4 2 - 4 4 2 \mathrm { m m o l / L }$

Linearity studies were performed to validate the measuring range of the assays. The samples were prepared with 11 concentrations with the range from lowest to the highest concentration. They analyzed each of levels for 4 times, and then calculated the linear deviation and linearity range in accordance with CLSI EP6-A document.

<table><tr><td colspan="4">Glucose Linearity Percent Difference</td></tr><tr><td>Ranks</td><td>Assigned (mg/dl)</td><td>% of mean of high 4 rep. Std. with</td><td>% diff. from assigned</td></tr><tr><td></td><td></td><td>saline 0</td><td></td></tr><tr><td>1 2</td><td>0</td><td>0.15%</td><td>0 0.00%</td></tr><tr><td>3</td><td>1</td><td>0.60%</td><td>1 0.00%</td></tr><tr><td>4</td><td>4</td><td>2.50%</td><td>4 0.00%</td></tr><tr><td>5</td><td>17</td><td>5%</td><td>17.25 1.47%</td></tr><tr><td>6</td><td>34</td><td>10%</td><td>34.5 1.47%</td></tr><tr><td>7</td><td>68</td><td>20%</td><td>68.25 0.37%</td></tr><tr><td>8</td><td>136</td><td>30%</td><td>140 2.94%</td></tr><tr><td>9</td><td>204</td><td>50%</td><td>211 3.43%</td></tr><tr><td></td><td>340</td><td></td><td>342.5 0.74%</td></tr><tr><td>10</td><td>473</td><td>70%</td><td>479 1.27%</td></tr><tr><td>11</td><td>680</td><td>100%</td><td>686.25 0.92%</td></tr></table>

$$
\begin{array} { c } { { \mathrm { y } = 1 . 0 0 3 \mathrm { x } + 1 . 8 8 6 4 } } \\ { { \mathrm { r } ^ { 2 } { = } 0 . 9 9 9 8 } } \end{array}
$$

<table><tr><td colspan="4">Serum Potassium Linearity Percent Difference</td><td rowspan="2">% diff. from</td></tr><tr><td>Ranks</td><td>Assigned (mg/dl)</td><td>ratio of high to</td><td>mean of 4 rep.</td></tr><tr><td></td><td></td><td>low std.</td><td></td><td>assigned</td></tr><tr><td>1</td><td>1.08</td><td>0:1</td><td>1.075</td><td>0.00%</td></tr><tr><td>2</td><td>1.84</td><td>1:9</td><td>1.875</td><td>1.90%</td></tr><tr><td>3</td><td>2.6</td><td>2:8</td><td>2.600</td><td>0.00%</td></tr><tr><td>4</td><td>3.36</td><td>3:7</td><td>3.200</td><td>-4.76%</td></tr><tr><td>5</td><td>4.12</td><td>4:6</td><td>4.300</td><td>4.37%</td></tr><tr><td>6</td><td>4.88</td><td>5:5</td><td>4.925</td><td>0.92%</td></tr><tr><td>7</td><td>5.64</td><td>6:4</td><td>5.700</td><td>1.06%</td></tr><tr><td>8</td><td>6.4</td><td>7:3</td><td>6.225</td><td></td></tr><tr><td>9</td><td></td><td>8:2</td><td></td><td>-2.73%</td></tr><tr><td>10</td><td>7.16</td><td>9:1</td><td>7.025 7.925</td><td>-1.89%</td></tr><tr><td>11</td><td>7.92 8.68</td><td>1:0</td><td>8.675</td><td>0.06% -0.06%</td></tr><tr><td colspan="5">y = 0.9919x + 0.0253 r2= 0.9981</td></tr><tr><td colspan="5">Serum Sodium Linearity Percent Difference Ranks Assigned</td></tr><tr><td></td><td>(mg/dl)</td><td>high to low std.</td><td>mean of 4 rep.</td><td>% diff. from assigned</td></tr><tr><td>1 2</td><td>114</td><td>0:1 1:9</td><td>114.00</td><td>0.00%</td></tr><tr><td>3</td><td>122.2</td><td>2:8</td><td>122.75</td><td>0.45%</td></tr><tr><td>4</td><td>130.4</td><td>3:7</td><td>129.50</td><td>-0.69%</td></tr><tr><td>5</td><td>138.5</td><td>4:6</td><td>135.50</td><td>-2.17%</td></tr><tr><td>6</td><td>146.7</td><td>5:5</td><td>148.25</td><td>1.06%</td></tr><tr><td>7</td><td>154.9</td><td>6:4</td><td>154.75</td><td>-0.10%</td></tr><tr><td>8</td><td>163.1</td><td>7:3</td><td>163.25</td><td>0.09%</td></tr><tr><td>9</td><td>171.2</td><td>8:2</td><td>168.25</td><td>-1.72%</td></tr><tr><td>10</td><td>179.4</td><td>9:1</td><td>178.00</td><td>-0.78%</td></tr><tr><td>11</td><td>187.6 195</td><td>1:0</td><td>187.25</td><td>-0.19% 0.38%</td></tr><tr><td></td><td>y = 0.9969x - 0.0461</td><td></td><td>195.75</td><td></td></tr><tr><td colspan="5">r2= 0.9967 Serum Chloride Linearity Percent Difference</td></tr><tr><td>Ranks</td><td>Assigned (mg/dl)</td><td>ratio of high to</td><td>mean of 4 rep.</td><td>% diff. from</td></tr><tr><td>1</td><td></td><td>low std. 0:1</td><td></td><td>assigned</td></tr><tr><td>2</td><td>52.8 63</td><td>1:9</td><td>52.75</td><td>0.00%</td></tr><tr><td>3</td><td></td><td>2:8</td><td>64.00</td><td>1.59% -1.64%</td></tr><tr><td>4</td><td>73.2</td><td>3:7</td><td>72.00</td><td></td></tr><tr><td>5</td><td>83.4</td><td>4:6</td><td>80.25</td><td>-3.78%</td></tr><tr><td>6</td><td>93.7</td><td>5:5</td><td>95.50</td><td>1.92%</td></tr><tr><td>7</td><td>103.9</td><td>6:4</td><td>104.25</td><td>0.34%</td></tr><tr><td></td><td>114.1</td><td></td><td>114.75</td><td>0.57%</td></tr><tr><td>8</td><td>124.3</td><td>7:3</td><td>122.25</td><td>-1.65%</td></tr><tr><td>9</td><td>134.6</td><td>8:2</td><td>133.25</td><td>-1.00%</td></tr><tr><td>10</td><td>144.8</td><td>9:1</td><td>144.25</td><td>-0.38%</td></tr><tr><td>11</td><td>155</td><td>1:0</td><td>155.00</td><td>0.00%</td></tr><tr><td colspan="5">Urine Potassium Linearity Percent Difference</td></tr><tr><td>Ranks</td><td>Assigned (mg/dl)</td><td>ratio of high to low std.</td><td>mean of 4 rep.</td><td>% diff. from assigned</td></tr><tr><td>1</td><td>11</td><td>0:1</td><td>11.00</td><td>0.00%</td></tr><tr><td>2</td><td>28.21</td><td>1:9</td><td>29.40</td><td>4.22%</td></tr><tr><td>3</td><td>45.41</td><td>2:8</td><td>47.15</td><td>3.83%</td></tr><tr><td>4</td><td>62.62</td><td>3:7</td><td>65.25</td><td>4.20%</td></tr><tr><td>5</td><td>79.82</td><td>4:6</td><td>82.20</td><td>2.98%</td></tr><tr><td>6</td><td>97.03</td><td>5:5</td><td>99.50</td><td>2.55%</td></tr><tr><td>7</td><td>114.23</td><td>6:4</td><td>115.88</td><td>1.44%</td></tr><tr><td>8</td><td>131.44</td><td>7:3</td><td>132.90</td><td>1.11%</td></tr><tr><td>9</td><td>148.64</td><td>8:2</td><td>149.93</td><td>0.86%</td></tr><tr><td>10</td><td>165.84</td><td>9:1</td><td>165.23</td><td>-0.37%</td></tr><tr><td>11</td><td>183.05</td><td>1:0</td><td>183.05</td><td>0.00%</td></tr></table>

$$
\begin{array} { c } { { \mathrm { y } = 0 . 9 9 3 8 \mathrm { x } - 1 . 8 8 7 3 } } \\ { { \mathrm { r } ^ { 2 } { = } 0 . 9 9 9 4 } } \end{array}
$$

<table><tr><td colspan="5">Urine Sodium Linearity Percent Difference</td></tr><tr><td>Ranks</td><td>Assigned (mg/dl)</td><td>ratio of high to low std.</td><td>mean of 4 rep.</td><td>% diff. from</td></tr><tr><td>1</td><td></td><td>0:1</td><td></td><td>assigned</td></tr><tr><td>2</td><td>21</td><td>1:9</td><td>21.00</td><td>0.00%</td></tr><tr><td>3</td><td>55.9</td><td>2:8</td><td>61.25</td><td>9.57%</td></tr><tr><td>4</td><td>90.8</td><td>3:7</td><td>96.75</td><td>6.55%</td></tr><tr><td>5</td><td>125.8</td><td>4:6</td><td>132.75</td><td>5.52%</td></tr><tr><td>6</td><td>160.7</td><td>5:5</td><td>166.50</td><td>3.61%</td></tr><tr><td></td><td>195.6</td><td></td><td>202.25</td><td>3.40%</td></tr><tr><td>7</td><td>230.6</td><td>6:4</td><td>236.50</td><td>2.56%</td></tr><tr><td>8</td><td>265.5</td><td>7:3</td><td>268.50</td><td>1.13%</td></tr><tr><td>9</td><td>300.4</td><td>8:2</td><td>301.00</td><td>0.20%</td></tr><tr><td>10 11</td><td>335.3 370.3</td><td>9:1 1:0</td><td>335.75 370.25</td><td>0.13% -0.01%</td></tr><tr><td colspan="5">Urine Chloride Linearity Percent Difference</td></tr><tr><td>Ranks</td><td>Assigned (mg/dl)</td><td>ratio of high to low std.</td><td>mean of 4 rep.</td><td>% diff. from</td></tr><tr><td>1</td><td></td><td>0:1</td><td></td><td>assigned</td></tr><tr><td>2</td><td>5</td><td>1:9</td><td>5.00</td><td>0.00%</td></tr><tr><td>3</td><td>47</td><td>2:8</td><td>44.75</td><td>-4.79%</td></tr><tr><td>4</td><td>88.9</td><td>3:7</td><td>84.00</td><td>-5.51%</td></tr><tr><td>5</td><td>130.8</td><td>4:6</td><td>122.75</td><td>-6.15%</td></tr><tr><td>6</td><td>172.8</td><td>5:5</td><td>166.25</td><td>-3.79%</td></tr><tr><td>7</td><td>214.8</td><td>6:4</td><td>209.25</td><td>-2.58%</td></tr><tr><td>8</td><td>256.7</td><td>7:3</td><td>251.00</td><td>-2.22%</td></tr><tr><td>9</td><td>298.6</td><td>8:2</td><td>294.25</td><td>-1.46%</td></tr><tr><td>10</td><td>340.6</td><td>9:1</td><td>338.25</td><td>-0.69%</td></tr><tr><td>11</td><td>382.6 424.5</td><td>1:0</td><td>383.50 424.50</td><td>0.24% 0.00%</td></tr></table>

$$
\begin{array} { c } { { \mathrm { y } = 1 . 0 0 6 2 - 4 . 8 5 4 1 } } \\ { { \mathrm { r } ^ { 2 } { = } 0 . 9 9 9 5 } } \end{array}
$$

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

The applicant is not making a claim for a glucose calibrator or control but is recommending the use of an NIST-traceable Glucose Standard $\left( 1 0 0 \mathrm { m g / d l } \right)$ or serum calibrator. The glucose studies were conducted using the calibrator cleared under k810674.

Cleared under Medica EasyElectroLyte/RapidLyte Na/K/Cl Analyzer (k000926)

d. Detection limit:

Glucose

The lower limit of the reportable range is $1 . 0 \mathrm { m g / d l }$ , which was defined by the sponsor as the lowest measurable analyte level with a CV less then or equal to $20 \%$ . The studies were conducted for 10 days with two runs per day using serum sample containing the analyte at $\mathrm { { 1 m g / d l } }$ concentration.

The lower limit of the measuring range for the ISE assays was determined from the linear range study above.

e. Analytical specificity:

The applicant references Young, et al (Young, D.S., et al, Clin. Chem. 21:1D (1975)) for drugs and substances that may affect glucose values.

The applicant has tested glucose for the following:

Bilirubin to the level of $1 8 \mathrm { m g / d l }$ has been found to exhibit $\leq 1 0 \%$ interference in this assay. Hemoglobin to the level of $2 5 0 \mathrm { m g / d l }$ has been found to exhibit $\leq 1 0 \%$ interference in this assay. Intralipid has been found to exhibit $\leq 1 0 \%$ interference in this assay to a level of $3 0 0 \mathrm { m g / d l }$ .

The applicant has tested all the ISE assays for the following:

Bilirubin to the level of $2 0 \mathrm { m g / d l }$ has been found to exhibit $\leq 1 0 \%$ interference in this assay. Hemoglobin\* to the level of $5 0 0 \mathrm { m g / d l }$ has been found to exhibit $\leq 1 0 \%$ interference in this assay. Intralipid has been found to exhibit $\leq 1 0 \%$ interference in this assay to a level of $1 0 0 0 \mathrm { m g / d l }$ .

Hemolysis: Hemoglobin had no interference with $\mathrm { K } ^ { + }$ due to the nature of the commercial Hemoglobin product having no $\mathrm { K } ^ { + }$ ion. However, hemolysis will interfere with $\mathrm { K } ^ { + }$ due to the high $\mathrm { K } ^ { + }$ concentration in erythrocytes. The sponsor has listed this interference in the PI.

f. Assay cut-off: Not Applicable

2. Comparison studies:

a. Method comparison with predicate device:

Method comparison using serum samples (vs. Hitachi 917)

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>r</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Range</td></tr><tr><td rowspan=1 colspan=1>GLU (mg/dL)</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0.9992</td><td rowspan=1 colspan=1>1.015</td><td rowspan=1 colspan=1>-0.0288</td><td rowspan=1 colspan=1>27-593</td></tr></table>

Method comparison using serum samples (vs. EasyElectrolytes $\mathrm { K } / \mathrm { N a } / \mathrm { C l } )$ )

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>r</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Range</td></tr><tr><td rowspan=1 colspan=1>K (mmol/L)</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0.9983</td><td rowspan=1 colspan=1>0.986</td><td rowspan=1 colspan=1>0.124</td><td rowspan=1 colspan=1>2.9-6.9</td></tr><tr><td rowspan=1 colspan=1>Na (mmol/L)</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0.9868</td><td rowspan=1 colspan=1>1.007</td><td rowspan=1 colspan=1>-1.1</td><td rowspan=1 colspan=1>129.3-176.4</td></tr><tr><td rowspan=1 colspan=1>CL (mmol/L)</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0.9894</td><td rowspan=1 colspan=1>0.973</td><td rowspan=1 colspan=1>4.35</td><td rowspan=1 colspan=1>75.6-129.8</td></tr></table>

Method comparison using diluted urine samples (vs. EasyElectrolytes K/Na/Cl)

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>r</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Range</td></tr><tr><td rowspan=1 colspan=1>K (mmol/L)</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0.9992</td><td rowspan=1 colspan=1>0.967</td><td rowspan=1 colspan=1>0.34</td><td rowspan=1 colspan=1>11-84.4</td></tr><tr><td rowspan=1 colspan=1>Na (mmol/L)</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0.9974</td><td rowspan=1 colspan=1>0.949</td><td rowspan=1 colspan=1>-4.2</td><td rowspan=1 colspan=1>21-218</td></tr><tr><td rowspan=1 colspan=1>CL (mmol/L)</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0.9895</td><td rowspan=1 colspan=1>0.997</td><td rowspan=1 colspan=1>-6.5</td><td rowspan=1 colspan=1>62-286</td></tr></table>

$b$ . Matrix comparison: The plasma claim for the ISE electrodes was previously cleared under the Medica EasyElectroLyte/RapidLyte $\mathrm { N a } / \mathrm { K } / \mathrm { C l }$ Analyzer (k000926).

3. Clinical studies:

a. Clinical Sensitivity: Not Applicable

b. Clinical specificity: Not Applicable

c. Other clinical supportive data (when a. and b. are not applicable): Not Applicable

4. Clinical cut-off: Not Applicable

5. Expected values/Reference range:

Glucose Normal range - 74-106 mg/dl (as referenced by Tietz, N.W., Text Book of Clinical Chemistry, Philadelphia, W.B. Saunders, p.782 (1999))

ISE normal ranges Chloride – serum: 98-107 mmol/L, 24 hour urine: $1 1 0 { - } 2 5 0 \ \mathrm { m m o l / L }$ Sodium – serum: 136-145 mmol/L, 24 hour urine: $4 0 { - } 2 2 0 \ \mathrm { m m o l / L }$ Potassium – serum: 3.5-5.1 mmol/L, 24 hour urine: $2 5 { \mathrm { - } } 1 2 5 { \mathrm { ~ m m o l / L } }$ (as referenced by Tietz, N.W., Clinical Guide to Laboratory Tests, Philadelphia, W.B. Saunders, (1990))

# N. Instrument Name:

Mindray, BS 200 Chemistry Analyzer

# O. System Descriptions:

1. Modes of Operation: Random access instrument with ISE module

2. Software:

FDA has reviewed applicant’s Hazard Analysis and software development processes for this line of product types:

Yes __X_ ___ or No

3. Specimen Identification: Sample bar code option

4. Specimen Sampling and Handling: Random access and stat mode operation Samples are loaded on reagent wheel

5. Calibration: Endpoint with sample blanking Fixed-time Kinetic Linear calibration and nonlinear calibration methods

6. Quality Control: Includes quality control program

P. Other Supportive Instrument Performance Characteristics Data Not Covered In The “Performance Characteristics” Section above: Not Applicable

Proposed Labeling: The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# R. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.